Molecular Basis of Binding Interactions of NSAIDs and Computer-Aided Drug Design Approaches in the Pursuit of the Development of Cyclooxygenase-2 (COX-2) Selective Inhibitors

doi 10.5772/intechopen.68318
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis

Archives of Internal Medicine
2000English

Reduction in Cancer Risk by Selective and Nonselective Cyclooxygenase-2 (COX-2) Inhibitors

Journal of Experimental Pharmacology
Molecular MedicinePharmacology
2012English

Role of the Selective Cyclo-Oxygenase-2 (COX-2) Inhibitors in Children

Archives of Disease in Childhood: Education and Practice Edition
Child HealthPediatricsPerinatology
2004English

Editorial: Gastrointestinal Safety of COX-2 Selective and Nonselective NSAIDs-the Impact of the PRECISION Trial

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: How Strong Is the Evidence?

BMJ
2005English

The Binding of Arachidonic Acid in the Cyclooxygenase Active Site of Mouse Prostaglandin Endoperoxide Synthase-2 (COX-2)

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

COX-1 and COX-2 Products in the Gut: Therapeutic Impact of COX-2 Inhibitors

Gut
Gastroenterology
2000English

Editorial: Gastrointestinal Safety of COX-2 Selective and Nonselective NSAIDs-the Impact of the PRECISION Trial. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Cytotoxic of Ganoderma Lucidum in Colon Cancer Through Cyclooxygenase 2 (COX-2) as Its Molecular Target

Journal of Tropical Life Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy